Dick E. de Vries
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- T-cell and B-cell Immunology
- Biosimilars and Bioanalytical Methods
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
- Systemic Lupus Erythematosus Research 2
-
- Biosimilars and Bioanalytical Methods 2
- Toxin Mechanisms and Immunotoxins 1
- T-cell and B-cell Immunology 1
- Co-authors
- Yanli Zhuang (4 shared papers)Honghui Zhou (4 shared papers)Hugh M. Davis (4 shared papers)Zhenhua Xu (4 shared papers)Filippa Nyberg (2 shared papers)Annegret Kuhn (2 shared papers)Jacek C. Szepietowski (2 shared papers)Adam Reich (2 shared papers)
- Journals
- Clinical Therapeutics (1 paper)The Journal of Clinical Pharmacology (1 paper)Advances in Therapy (1 paper)Journal of Investigative Dermatology (1 paper)International Journal of Clinical Pharmacology and Therapeutics (1 paper)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Dick E. de Vries
7 papers receiving 331 citations
Peers
Comparison fields: 5 of 44
- Rheumatology 178
- Immunology 127
- Pharmacology 40
- Biological Psychiatry 10
- Radiology, Nuclear Medicine and Imaging 84
Countries citing papers authored by Dick E. de Vries
This map shows the geographic impact of Dick E. de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick E. de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick E. de Vries more than expected).
Fields of papers citing papers by Dick E. de Vries
This network shows the impact of papers produced by Dick E. de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick E. de Vries. The network helps show where Dick E. de Vries may publish in the future.
Co-authors
The 25 scholars most cited alongside Dick E. de Vries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 97 | |
| 2 | 2015 | 71 | |
| 3 | 2011 | 69 | |
| 4 | 2011 | 44 | |
| 5 | 2022 | 31 | |
| 6 | 2013 | 20 | |
| 7 | 2017 | 9 |
About Dick E. de Vries
Dick E. de Vries is a scholar working on Rheumatology, Immunology, Oncology, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 341 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Toxin Mechanisms and Immunotoxins (1 paper), T-cell and B-cell Immunology (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Rheumatology (178 citations), Immunology (127 citations), Pharmacology (40 citations), Biological Psychiatry (10 citations) and Radiology, Nuclear Medicine and Imaging (84 citations). Dick E. de Vries has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Yanli Zhuang, Honghui Zhou, Hugh M. Davis, Zhenhua Xu, Filippa Nyberg, Annegret Kuhn, Jacek C. Szepietowski, Adam Reich, Anna Woźniacka and Francisco León. Their work appears in journals such as Clinical Therapeutics, The Journal of Clinical Pharmacology, Advances in Therapy, Journal of Investigative Dermatology and International Journal of Clinical Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.